Pro-Dex, Inc. (PDEX) has a MoatMap StockRank of 94/100 based on Quality (73/100), Value (37/100), and Momentum (74/100) factor scores. The current signal is STRONG BUY. Pro-Dex designs and manufactures high-quality surgical power tools for major medical device OEMs. It operates a high-moat, high-switching-cost business with strong ROIC. While it benefits from medical manufacturing localization trends, its microcap scale and customer concentration limit its immediate suitability for a concentrated global fund.
Pro-Dex, Inc. is a specialized manufacturer of powered surgical instruments for medical device OEMs, including robotic surgical systems, and rotary handpieces for dental applications. The company's competitive edge stems from its deep expertise in high-precision, miniature powered rotary instruments, coupled with strong engineering capabilities and a track record of quality and reliability. Pro-Dex serves as a critical, niche supplier within the medical and dental industries, leveraging its specialized manufacturing and development capabilities.
| Price | $65.00 |
| Market Cap | $216M |
| P/E (TTM) | 18.46 |
| P/E (Forward) | 32.52 |
| Price/Book | 4.74 |
| Return on Equity | 29.8% |
| Return on Invested Capital | 27.7% |
| Debt/Equity | 44.63 |
| Gross Margin | 27.8% |
| Operating Margin | 15.5% |
| Revenue Growth | 14.6% |
| Free Cash Flow | $5M |
Pro-Dex, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).